Perfusion System Market Size

Perfusion System Market Analysis

The Perfusion System Market is expected to register a CAGR of 8.2% over the forecast period.

The pandemic has impacted the studied market. In spite of the high prevalence of cardiovascular and respiratory diseases, the majority of cardiac surgical procedures were postponed or canceled, and the number of organ donations and transplants decreased significantly due to the pandemic outbreak. As a result, during the pandemic, the market witnessed a slight drop in perfusion system sales. For instance, as per the press release by XVIVO Perfusion AB in March 2021, due to the Covid-19 pandemic, XVIVO Perfusion witnessed a decrease in demand for transplant products in 2020. This has had a detrimental influence on XVIVO Perfusion system sales in the first quarter of 2020. The company also said that the sales fell around 15.0% less than the previous year during the first quarter. Thus, owing to the reduced demand for perfusion systems, the market witnessed a slight adverse impact during the pandemic. However, with the resumption of surgical procedures, organ transplantation procedures, declining cases of COVID-19, and ease of restrictions, the market has started to gain traction. It is expected to continue the upward trend over the forecast period.

The rising demand for organ transplantation, an increase in the prevalence of cardiovascular and respiratory diseases, and rising initiatives by the government and various organizations to promote organ donations are the major factors propelling the market growth. For instance, as per the data published by the Health Resources and Services Administration in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 live transplants were performed in 2021 in the United States. The perfusion system is one of the essential requirements for organ preservation and transplantation; thus increasing number of organ transplants is anticipated to increase the demand for perfusion system. In addition, there is a rising prevalence of cardiovascular and respiratory diseases across the globe is also boosting the demand for organ transplantation, which in turn propelling the market growth. For instance, according to the WHO 2021 factsheet, asthma is a major NCD affecting both children and adults. Globally, asthma affected more than 262.0 million people in 2021 and caused more than 461,000 deaths.

Furthermore, as per the research study published by the European Respiratory Society (ERS) published in 2021, ERS estimated that there were 36,580,965 Europeans with COPD, and the number is projected to reach 49,453,852 people by the year 2050. Thus, owing to the rising demand for organ transplantation and an increase in the prevalence of respiratory diseases, the market is expected to witness high growth. Moreover, rising product launches by the key market players are also anticipated to boost market growth. For instance, in December 2021, OrganOx, a manufacturer of normothermic machine perfusion (NMP), received premarket clearance (PMA) from the U.S. FDA for its metra system. The OrganOx metra is a fully automated NMP system that is used to preserve and transport donor livers for transplantation. Thus, owing to product launches and rising organ transplantation procedures, considerable market growth is expected over the forecast period.

However, the high cost of the devices and organ transplantation may restrain the market growth over the forecast period.